Ideas
AMD leads semis with CPU, GPU strength.
AMD is the leading semiconductor stock with both GPU and CPU exposure. The CPU cycle is set to be the main character this earnings season, and AMD's strong resilience during the July sell-off confirms its leadership. Despite after-hours disappointment, AMD remains critically important and can recover once management addresses capex and guidance concerns.
S&P 500 all-time high, bull intact.
S&P 500 hit a new all-time high, confirming that the July sell-off was a reset, not the end of the bull market. Excessive leverage has been cleaned out, and momentum indicators suggest room for further upside, with Societe Generale targeting 8000.
Palantir commercial revenue boom drives rally.
Palantir's commercial revenue surged 150%, validating that AI model diversification and open-weight trends increase demand for Palantir's decision-optimization platform. The company is well-positioned as an AI winner, and even Michael Burry closed his Palantir puts, signaling near-term upside.
Chinese optics ban benefits Lumentum, Marvell.
The U.S. preparing to ban Chinese optical transceivers is a direct catalyst for U.S. optical communication stocks like Lumentum and Marvell, which already rallied on the news and offer continued momentum.
Memory chips are a post-selloff buy opportunity.
Memory semiconductors, especially SK hynix and Micron, became a buying opportunity after the July decline. Wall Street issued a wave of target price upgrades, citing AI demand tailwinds and attractive valuations.
Arista Networks rebound on cheap valuation.
Arista Networks delivered good earnings and had been unfairly undervalued, leading to a sharp after-hours rebound. The stock's cheap valuation relative to peers creates a buying opportunity.
Caterpillar benefits from AI data center power.
Caterpillar delivered strong earnings and highlighted AI data center backup power as a new growth driver, while also having capacity for share buybacks, driving the stock sharply higher.
Alteogen gains on Keytruda sales growth.
Alteogen benefits from Merck's Keytruda sales growth (up 5% YoY) and Merck's continued focus on obesity drug development, creating a positive setup for the Korean biotech linked to Keytruda technology.
Kratos earnings explode on drone demand.
Kratos Defense, a drone company, reported EPS up 91% year-over-year, reflecting the rising importance of drones in modern warfare, and the stock surged on the results.
This 3PRO TV (삼프로TV) video, published August 04, 2026,
features Park Myung-seok
discussing AMD, SPY, PLTR, LITE, MRVL, KS, MU, ANET, CAT, KQ, KTOS.
9 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Park Myung-seok
· Tickers:
AMD,
SPY,
PLTR,
LITE,
MRVL,
KS,
MU,
ANET,
CAT,
KQ,
KTOS